Earnings To Watch: USANA (USNA) Reports Q2 Results Tomorrow
USANA Health Sciences (NYSE:USNA) is set to report Q2 earnings Tuesday after the bell. Last quarter, it reported $250.2M revenue, flat YoY, and beat analysts on EBITDA and EPS. For Q2, analysts expect flat YoY revenue, after a 10.8% rise last year. The article cites an average analyst price target of $39 versus $22.11.
How this was made
The 30-second read
Why it matters
Traders can use the setup to position for earnings volatility, but the text does not disclose any new company-specific datapoint beyond expectations and recent history.
Market read
This is a pre-earnings checklist: flat YoY revenue expectations, reconfirmed estimates, and a reminder that USANA has missed revenue estimates multiple times.
What to watch
The article does not discuss guidance, margins, or specific drivers for USANA’s quarter, so traders may be underweighting qualitative commentary risk.
Background
USANA Health Sciences is heading into its Q2 earnings report after the bell Tuesday; the article summarizes prior-quarter beats and current consensus.
Ticker impact
USANA is scheduled to report Q2 earnings after the bell, with the article outlining consensus expectations and recent estimate history.
Likely volatility around the after-hours earnings release, with direction dependent on revenue and margin/EPS beats versus expectations.
The article provides consensus framing (flat YoY revenue) and notes USANA has missed revenue estimates multiple times, which increases downside risk if revenue disappoints.
Market effects
Limited, since it mainly compares consumer-staples peers’ Q2 results without implying a direct read-across mechanism.
None specified.
None specified.
Counterpoint
If peers’ strong top-line prints (Vita Coco, WD-40) signal demand resilience, USANA could surprise on revenue despite its recent misses.
Key entities
- companyUSANA Health Sciences
Subject of the earnings preview, expected to report Q2 results after the bell Tuesday.
